Comparison of platelet immunity in patients with SLE and with ITP.

[1]  A. Lazarus,et al.  Analysis of transmembrane signalling and T cell defects associated with idiopathic thrombocytopenic purpura (ITP) , 1998, Acta paediatrica (Oslo, Norway : 1992). Supplement.

[2]  J. Freedman,et al.  Reticulated platelet counts in the assessment of thrombocytopenic disorders , 1998, Acta paediatrica (Oslo, Norway : 1992). Supplement.

[3]  S. Nomura,et al.  Clinical significance of HLA-DRB1*0410 in Japanese patients with idiopathic thrombocytopenic purpura. , 1998, Blood.

[4]  G. Trinchieri,et al.  Decreased production of interleukin-12 and other Th1-type cytokines in patients with recent-onset systemic lupus erythematosus. , 1998, Arthritis and rheumatism.

[5]  Junga Lee,et al.  Elevated interleukin-10 levels correlated with disease activity in systemic lupus erythematosus. , 1998, Clinical and experimental rheumatology.

[6]  T. Liu,et al.  Impaired production of IL-12 in systemic lupus erythematosus. I. Excessive production of IL-10 suppresses production of IL-12 by monocytes. , 1998, Cytokine.

[7]  T. Liu,et al.  Impaired production of IL-12 in system lupus erythematosus. II: IL-12 production in vitro is correlated negatively with serum IL-10, positively with serum IFN-gamma and negatively with disease activity in SLE. , 1998, Cytokine.

[8]  R. Warrington,et al.  Interleukin‐10 Response Abnormalities in Systemic Lupus Erythematosus , 1997, Scandinavian journal of immunology.

[9]  M. Fenton,et al.  IL-15 functions as a potent autocrine regulator of macrophage proinflammatory cytokine production: evidence for differential receptor subunit utilization associated with stimulation or inhibition. , 1997, Journal of immunology.

[10]  W. Mayr,et al.  Lupus anticoagulants: strong association with the major histocompatibility complex class II and platelet antibodies , 1997, British journal of haematology.

[11]  D. Alarcón-Segovia,et al.  Dysregulation of interleukin-10 production in relatives of patients with systemic lupus erythematosus. , 1997, Arthritis and rheumatism.

[12]  J. Lacki,et al.  Cytokine concentration in serum of lupus erythematosus patients: the effect on acute phase response. , 1997, Journal of medicine.

[13]  S. Studenski,et al.  Mortality risks associated with specific clinical manifestations of systemic lupus erythematosus. , 1996, Archives of internal medicine.

[14]  J. Freedman,et al.  Differences in serum cytokine levels in acute and chronic autoimmune thrombocytopenic purpura: relationship to platelet phenotype and antiplatelet T-cell reactivity. , 1996, Blood.

[15]  F. Nicoletti,et al.  In vitro type-1 and type-2 cytokine production in systemic lupus erythematosus: lack of relationship with clinical disease activity , 1996, Lupus.

[16]  D. Klinman,et al.  Disease severity in patients with systemic lupus erythematosus correlates with an increased ratio of interleukin-10:interferon-gamma-secreting cells in the peripheral blood. , 1996, Arthritis and rheumatism.

[17]  J. Bussel,et al.  Serum levels of GM‐CSF are elevated in patients with thrombocytopenia , 1996, British journal of haematology.

[18]  J. Renauld,et al.  Serum interleukin 10 titers in systemic lupus erythematosus reflect disease activity , 1995, Lupus.

[19]  J. Semple,et al.  Abnormal cellular immune mechanisms associated with autoimmune thrombocytopenia. , 1995, Transfusion medicine reviews.

[20]  M. Álvarez-Mon,et al.  Abnormal gamma IFN and alpha TNF secretion in purified CD2+ cells from autoimmune thrombocytopenic purpura (ATP) patients: their implication in the clinical course of the disease. , 1995, American journal of hematology.

[21]  A. Jaramillo,et al.  Thymic T cell anergy in autoimmune nonobese diabetic mice is mediated by deficient T cell receptor regulation of the pathway of p21ras activation , 1993, The Journal of experimental medicine.

[22]  J. Nemunaitis,et al.  Increased macrophage colony-stimulating factor levels in immune thrombocytopenic purpura. , 1993, Blood.

[23]  R. Ware,et al.  Phenotypic and clonal analysis of T lymphocytes in childhood immune thrombocytopenic purpura. , 1993, Blood.

[24]  J. Kelton,et al.  HLA‐DR expression by platelets in acute idiopathic thrombocytopenic purpura , 1992, British journal of haematology.

[25]  J. Semple,et al.  Increased antiplatelet T helper lymphocyte reactivity in patients with autoimmune thrombocytopenia. , 1991, Blood.

[26]  M. Hadzija,et al.  Defective thymic T cell activation by concanavalin A and anti-CD3 in autoimmune nonobese diabetic mice. Evidence for thymic T cell anergy that correlates with the onset of insulitis. , 1991, Journal of immunology.

[27]  S. Karpatkin,et al.  In vitro suppressor T lymphocyte dysfunction in autoimmune thrombocytopenic purpura associated with a complement‐fixing antibody , 1990, British journal of haematology.

[28]  J F Fries,et al.  The 1982 revised criteria for the classification of systemic lupus erythematosus. , 1982, Arthritis and rheumatism.

[29]  S. Karpatkin,et al.  Impaired lymphocyte transformation and capping in autoimmune thrombocytopenic purpura. , 1979, Blood.